VACCINEX, INC. Annual Net Income (Loss) Attributable to Parent in USD from 2017 to 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Vaccinex, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2017 to 2023.
  • Vaccinex, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$5.63M, a 20.2% increase year-over-year.
  • Vaccinex, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$17.8M, a 18.8% increase year-over-year.
  • Vaccinex, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$20.3M, a 2.2% decline from 2022.
  • Vaccinex, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$19.8M, a 11.5% increase from 2021.
  • Vaccinex, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$22.4M, a 22.4% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$20.3M -$436K -2.2% Jan 1, 2023 Dec 31, 2023 10-K/A 2024-04-25
2022 -$19.8M +$2.57M +11.5% Jan 1, 2022 Dec 31, 2022 10-K/A 2024-04-25
2021 -$22.4M +$6.47M +22.4% Jan 1, 2021 Dec 31, 2021 10-K 2022-03-31
2020 -$28.9M +$3.01M +9.45% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-31
2019 -$31.9M -$2.35M -7.94% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-31
2018 -$29.5M -$10.8M -57.7% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-09
2017 -$18.7M Jan 1, 2017 Dec 31, 2017 10-K 2019-03-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.